Clinicopathological and Immunohistochemical Evaluation of Oral Epithelial Dysplasia with Emphasis on Cellular Proliferation and Molecular Alterations
Keywords:
Oral epithelial dysplasia, Ki-67, p53, Immunohistochemistry, Histopathology, Oral potentially malignant disordersAbstract
Introduction: Oral epithelial dysplasia (OED) is a potentially malignant disorder associated with an increased risk of developing oral squamous cell carcinoma. Conventional histopathological grading remains essential; however, its subjective nature highlights the need for additional biomarkers. This study evaluated the clinicopathological features of OED and investigated the expression of Ki-67 and p53 in relation to dysplasia grade.
Methodology: An analytical cross-sectional study was designed involving 100 oral epithelial dysplasia cases. Clinical and demographic information was recorded, and histopathological grading was performed on hematoxylin and eosin-stained sections. Immunohistochemical staining was conducted using Ki-67 and p53 markers. Associations between marker expression and dysplasia grades were assessed using appropriate statistical tests.
Results: Among the 100 cases, mild, moderate, and severe dysplasia accounted for 42%, 35%, and 23%, respectively. Mean Ki-67 labeling was significantly higher as the dysplasia progressed with a mean of 11.42% associated with severe dysplasia. 21.83%, and 44.91%, respectively (p<0.001). Higher grade lesions also showed higher Epithelial expression of Ki-67, both suprabasal and upper. The expression of p53 was more p53 expression was more moderate to strong in tumor cells than in the normal cells. Severe dysplasia (p=0.003) was more frequent than mild dysplasia. Both markers had strong significant positive correlations with dysplasia grade.
Conclusion: Ki-67 and p53 could be useful adjunctive immunohistochemical markers to assess the oral disease. In addition to the conventional histopathological grades, epithelial dysplasia was included. There are no additional prospective studies. needed to establish their prognostic value.
References
Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P. Management of oral epithelial dysplasia: a review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007 Mar 1;103:S19-e1.10.1016/j.tripleo.2006.10.015
Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Diseases. 2021 Nov;27(8):1947-76.https://doi.org/10.1111/odi.13993
Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia. Journal of oral pathology & medicine. 2009 Nov;38(10):737-52.https://doi.org/10.1111/j.1600-0714.2009.00804.x
Zdrojewski J, Nowak M, Nijakowski K, Jankowski J, Scribante A, Gallo S, Pascadopoli M, Surdacka A. Potential immunohistochemical biomarkers for grading oral dysplasia: a literature review. Biomedicines. 2024 Mar 5;12(3):577.https://doi.org/10.3390/biomedicines12030577
AbdulMajeed AA, Farah CS. Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?. Biomarkers in cancer. 2013 Jan;5:BIC-S12951.https://doi.org/10.1016/j.oooo.2023.03.005
AbdulMajeed AA, Farah CS. Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?. Biomarkers in cancer. 2013 Jan;5:BIC-S12951.https://doi.org/10.4137/BIC.S12951
Ranganathan K, Kavitha L. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders. Journal of oral and maxillofacial pathology: JOMFP. 2019 Jan;23(1):19.https://doi.org/10.4103/jomfp.JOMFP_13_19
Anu KR, Dosi AV, Samaddar JB, Eabenson S. INTEGRATED TRANSCRIPTOMIC AND IMMUNOHISTOCHEMICAL PROFILING OF INFLAMMATORY BIOMARKERS FOR EARLY PREDICTION OF ORAL EPITHELIAL DYSPLASIA PROGRESSION. Genetics and Molecular Research. 2026 Sep 14.https://doi.org/10.4238/3076mh73
de Morais EF, Pinheiro JC, Lira JA, Mafra RP, Barboza CA, de Souza LB, de Almeida Freitas R. Prognostic value of the immunohistochemical detection of epithelial-mesenchymal transition biomarkers in oral epithelial dysplasia: A systematic review. Medicina Oral, Patología Oral y Cirugía Bucal. 2020 Jan 22;25(2):e205.10.4317/medoral.23305
Bhagwath S. Histopathological and Molecular Characterization of Potentially Malignant Oral Disorders for Early Diagnosis and Prognostic Assessment. Journal of Intelligent Decision Making and Information Science. 2026 Aug 8;3(6s):1473-82.https://doi.org/10.59543/jidmis.v3.1513
Núñez MA, de Matos FR, de Almeida Freitas R, Galvão HC. Immunohistochemical study of integrin α5β1, fibronectin, and Bcl-2 in normal oral mucosa, inflammatory fibroepithelial hyperplasia, oral epithelial dysplasia, and oral squamous cell carcinoma. Applied Immunohistochemistry & Molecular Morphology. 2013 Jul 1;21(4):354-61.10.1097/PAI.0b013e318266c39d
Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral surgery, oral medicine, oral pathology and oral radiology. 2018 Jun 1;125(6):591-602.https://doi.org/10.1016/j.oooo.2018.02.012
Abbas MN, El-Sharkawy MS, Abbas ME, El-Shaer MM. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007 Mar 1;103(3):385-90.https://doi.org/10.1016/j.tripleo.2005.11.008
Soares, A.C., Silveira, F.M., Gomes, A.P.N. et al. Cell Proliferation, DNA Damage, and Apoptosis in Oral Leukoplakia and Oral Squamous Cell Carcinoma in Young Patients: A Comparative Immunohistochemical Study. Head and Neck Pathol 19, 91 (2025). https://doi.org/10.1007/s12105-025-01831-w
Patil P, Nandimath K, Prabhu S, Naikmasur VG. Heat shock protein (HSP70) as a marker of epithelial dysplasia in oral dysplastic lesions: A clinicopathological study. Journal of oral and maxillofacial pathology: JOMFP. 2015 Jan;19(1):53.https://doi.org/10.4103/0973-029X.157202
Becker AS, Holm M, Liese J, Engel N, Zimpfer AH. Diagnosis of differentiated dysplasia as a variant of oral epithelial dysplasia. Oral Diseases. 2024 Oct;30(7):4185-94.https://doi.org/10.1111/odi.14846
Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK. Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges. Periodontology 2000. 2019 Jun;80(1):126-47.https://doi.org/10.1111/prd.12259
Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa—Diagnostic problems and prognostic features. Current Diagnostic Pathology. 2006 Feb 1;12(1):11-21.https://doi.org/10.1016/j.cdip.2005.10.008
Puneeta N, Santosh T, Mishra I, Gaikwad P, Sahu A. Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma–An immunohistochemical study. Journal of Oral and Maxillofacial Pathology: JOMFP. 2022 Jun 28;26(2):285.https://doi.org/10.4103/jomfp.JOMFP_166_20
Condurache Hritcu OM, Botez AE, Olinici DT, Onofrei P, Stoica L, Grecu VB, Toader PM, Gheucă-Solovăstru L, Cotrutz EC. Molecular markers associated with potentially malignant oral lesions. Experimental and Therapeutic Medicine. 2021 Aug 1;22(2):1-5.https://doi.org/10.3892/etm.2021.10266
Woo, SB. Oral Epithelial Dysplasia and Premalignancy. Head and Neck Pathol 13, 423–439 (2019). https://doi.org/10.1007/s12105-019-01020-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.



